Page last updated: 2024-11-06

prednisolone and Chromosome Deletion

prednisolone has been researched along with Chromosome Deletion in 3 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Chromosome Deletion: Actual loss of portion of a chromosome.

Research Excerpts

ExcerptRelevanceReference
"We report a patient with acute myelomonocytic leukemia (AMMoL) who showed two independent point mutations of the N-ras gene at codons 12 and 13."1.29Double mutations of the N-ras gene in a patient with acute myelomonocytic leukemia. ( Hirakawa, K; Horiike, S; Kaneko, H; Kashima, K; Misawa, S; Nakai, H; Nakao, M; Taniwaki, M; Ueda, Y, 1995)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sylvan, SE1
Asklid, A1
Johansson, H1
Klintman, J1
Bjellvi, J1
Tolvgård, S1
Kimby, E1
Norin, S1
Andersson, PO1
Karlsson, C1
Karlsson, K1
Lauri, B1
Mattsson, M1
Sandstedt, AB1
Strandberg, M1
Österborg, A1
Hansson, L1
Lindhagen, E1
Norberg, M1
Kanduri, M1
Tobin, G1
Säisänen, L1
Aberg, M1
Gustafsson, MG1
Sundström, C1
Rosenquist, R1
Aleskog, A1
Horiike, S1
Misawa, S1
Kaneko, H1
Nakai, H1
Ueda, Y1
Nakao, M1
Hirakawa, K1
Taniwaki, M1
Kashima, K1

Trials

1 trial available for prednisolone and Chromosome Deletion

ArticleYear
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.
    Haematologica, 2019, Volume: 104, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydroch

2019

Other Studies

2 other studies available for prednisolone and Chromosome Deletion

ArticleYear
In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    European journal of haematology, 2009, Volume: 83, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Case-Control Studies; Chromosome Deletion; Ch

2009
Double mutations of the N-ras gene in a patient with acute myelomonocytic leukemia.
    International journal of hematology, 1995, Volume: 61, Issue:4

    Topics: Aclarubicin; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosom

1995